These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3003138)

  • 1. Determination of pentopril, an angiotensin converting enzyme inhibitor, and its active metabolite in urine.
    Tipnis V; Rakhit A
    J Chromatogr; 1985 Dec; 345(2):396-401. PubMed ID: 3003138
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of renal clearance of furosemide by pentopril, an angiotensin-converting enzyme inhibitor.
    Rakhit A; Kochak GM; Tipnis V; Hurley ME
    Clin Pharmacol Ther; 1987 May; 41(5):580-6. PubMed ID: 3032491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis.
    Bird HA; Le Gallez P; Dixon JS; Catalano MA; Traficante A; Liauw LA; Sussman H; Rotman H; Wright V
    J Rheumatol; 1990 May; 17(5):603-8. PubMed ID: 2359068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food on the bioavailability of pentopril, an angiotensin-converting-enzyme inhibitor, in healthy subjects.
    Rakhit A; Hurley ME; Redalieu E; Kochak G; Tipnis V; Coleman J; Rommel A
    J Clin Pharmacol; 1985 Sep; 25(6):424-8. PubMed ID: 2997306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid-chromatographic determination of an angiotensin converting enzyme inhibitor, CGS 13945, and its active metabolite (CGS 13934) in plasma.
    Rakhit A; Tipnis V
    Clin Chem; 1984 Jul; 30(7):1237-9. PubMed ID: 6329555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats.
    Rakhit A; Kochak G; Dotson R; Tipnis V
    J Pharm Sci; 1985 Sep; 74(9):947-52. PubMed ID: 2999376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renal impairment on disposition of pentopril and its active metabolite.
    Rakhit A; Radensky P; Szerlip HM; Kochak GM; Audet PR; Hurley ME; Feldman GM
    Clin Pharmacol Ther; 1988 Jul; 44(1):39-48. PubMed ID: 3391004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry.
    Kaiser G; Ackermann R; Dieterle W; Dubois JP
    J Chromatogr; 1987 Aug; 419():123-33. PubMed ID: 3667772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection.
    Sioufi A; Pommier F; Kaiser G; Dubois JP
    J Chromatogr; 1988 Dec; 434(1):239-46. PubMed ID: 3243821
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of a new angiotensin-converting enzyme inhibitor (CS-622) and its active metabolite in plasma and urine by gas chromatography-mass spectrometry using negative ion chemical ionization.
    Shioya H; Shimojo M; Kawahara Y
    J Chromatogr; 1989 Nov; 496(1):129-35. PubMed ID: 2592507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of pentopril in the elderly.
    Rakhit A; Kochak GM; Tipnis V; Radensky P; Hurley ME; Williams R
    Br J Clin Pharmacol; 1987 Sep; 24(3):351-7. PubMed ID: 2822067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation studies of di-acid angiotensin converting enzyme inhibitors.
    Drummer OH; Kourtis S; Iakovidis D
    Arzneimittelforschung; 1988 May; 38(5):647-50. PubMed ID: 3415707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas chromatography-mass spectrometry of perindopril and its active free metabolite, an angiotensin convertase inhibitor: choice of derivatives and ionization modes.
    Tsaconas C; Devissaguet M; Padieu P
    J Chromatogr; 1989 Mar; 488(1):249-65. PubMed ID: 2715284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor.
    Grislain L; Mocquard MT; Dabe JF; Bertrand M; Luijten W; Marchand B; Resplandy G; Devissaguet M
    Xenobiotica; 1990 Aug; 20(8):787-800. PubMed ID: 2219962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and determination of 4-hydroxyskatole sulfate ester.
    Mahon ME; Mattok GL
    Anal Biochem; 1967 Apr; 19(1):180-4. PubMed ID: 4292752
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenacein--an angiotensin-converting enzyme inhibitor produced by a streptomycete. II. Isolation, structure determination and synthesis.
    Liu WC; Parker WL; Brandt SS; Atwal KS; Ruby EP
    J Antibiot (Tokyo); 1984 Nov; 37(11):1313-9. PubMed ID: 6096341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum.
    Lecocq B; Funck-Brentano C; Lecocq V; Ferry A; Gardin ME; Devissaguet M; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):397-402. PubMed ID: 2311339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of metabolite pharmacokinetics for orally administered prodrugs.
    Kochak GM; Rakhit A
    Drug Metab Dispos; 1987; 15(4):456-9. PubMed ID: 2888616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the angiotensin converting enzyme inhibitor benazeprilat in plasma and urine by an enzymic method.
    Graf P; Frueh F; Schmid K
    J Chromatogr; 1988 Mar; 425(2):353-61. PubMed ID: 2836452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trandolapril in hypertension: overview of a new angiotensin-converting enzyme inhibitor.
    Duc LN; Brunner HR
    Am J Cardiol; 1992 Oct; 70(12):27D-34D. PubMed ID: 1414922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.